Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Vertex Pharmaceuticals    VRTX

VERTEX PHARMACEUTICALS

(VRTX)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on VERTEX PHARMACEUTICALS
07/31/19 Interim 2019 Earnings Release
07/31/19 | 04:30pm Interim 2019 Earnings Call
10/23/19 Q3 2019 Earnings Release (Projected)
01/29/20 FY 2019 Earnings Release (Projected)
Past events on VERTEX PHARMACEUTICALS
06/07/19 | 10:00am European Cystic Fibrosis Conference - Abstract Mark Chilvers
06/07/19 | 10:00am European Cystic Fibrosis Conference - Abstract Nataliya Volkova
06/07/19 | 09:00am European Cystic Fibrosis Conference - Abstract Edward McKone
06/07/19 | 09:00am European Cystic Fibrosis Conference - Teja Thorat
Upcoming sector events for VERTEX PHARMACEUTICALS
07/21/19 GILEAD SCIENCES, INC. : International aids society conference - poster no : lbpeb13
07/21/19 GILEAD SCIENCES, INC. : International aids society conference - poster no : tupea075
07/22/19 | 12:00pm GILEAD SCIENCES, INC. : International aids society conference - oral : moab0106
07/22/19 | 12:00pm GILEAD SCIENCES, INC. : International aids society conference - oral : moab0105
More events
Past sector events for VERTEX PHARMACEUTICALS
07/06/19 | 03:20am ARRAY BIOPHARMA INC : European Society for Medical Oncology World Gastrointestinal Cancer Congress - Abstract LBA-006
07/14/19 | 03:00pm GILEAD SCIENCES, INC. : Business Update Call
07/16/19 | 04:02pm SEATTLE GENETICS, INC. : Interim 2019 Earnings Release
07/16/19 | 04:30pm SEATTLE GENETICS, INC. : Interim 2019 Earnings Call
Annual publications
Annual results2016201720182019 (e)2020 (e)2021 (e)
Sales
M $
Released
Forecast
Spread
1 702
1 696
0,38%
2 489
2 431
2,4%
3 048
2 992
1,9%

3 559

4 405

5 412
Operating income
(EBITDA)
M $
Released
Forecast
Spread
71,3
58,7
22%
185
119
56%
1 184
1 123
5,4%

1 489

2 167

3 082
Operating profit
(EBIT)
M $
Released
Forecast
Spread
288
278
3,8%
564
538
4,9%
1 112
1 052
5,7%

1 441

2 111

3 009
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-67,4
-91,9
27%
-15,7
-70,5
78%
600
771
-22%

1 076

1 547

2 348
Net income
M $
Released
Forecast
Spread
-112
-135
17%
263
237
11%
2 097
740
183%

849

1 264

1 922
EPS
 $
Released
Forecast
Spread
-0,46
-0,55
17%
1,04
0,90
15%
8,09
2,84
185%

3,23

4,79

7,34
Announcement Date01/25/201701/31/201802/05/2019

Assessed data source
© 2019 S&P Global Market Intelligence
© 2019 Factset
Net sales (Year) - Rate of surprise
Operating profit (Year) - Rate of surprise
EPS (Year) - Rate of surprise